Abstract

There were carried out the analysis of the results the study of Vazonat (meldonium) efficiency in 55 patients with the type 2 diabetes mellitus (DM) during 12 weeks. Therapy with meldonium statistically improves the indexes of the kidney functional state, that showed up to the significantly decrease of microalbuminuria. creatinine and increases of glomerular filtration rate. In type 2 DM patients Vazonat improves the heart morphological and functional parameters, has additional nephroprotective effect, reduces content of triglycerides and low-density lipoproteins in comparing to base therapy. Taking into account hypoglycemic effect and positive influence on lipid metabolism, displays of diabetic nephropathy, Vazonat is recommended to plugging in the therapy of DM patients, especially for persons with the high risk of cardiovascular diseases. The next chart of Vazonat setting is recommended for patients with type 2 DM: tablets 500 mg twice on twenty-four hours in the first half of day during 12 weeks

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.